Technology & Software Global On demand · 24-48h

Global Biostorage Service Market Strategic Research Report

Global Biostorage Service Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Biostorage Service Market
$6892025
12.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Room Temperature Storage, Refrigerated Storage, Frozen Storage, Ultra Low Temperature Storage, Liquid Nitrogen Storage

By Application: Life Sciences and Medicine, Hospital, Government and Scientific Research Institutions, Chemical Industry, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Azenta, EPL Archives (VWR), Thermo Fisher Scientific, Precision for Medicine, Kryosphere, Cryoport Inc, Masy BioServices (Alcami), SciSafe (BioLife Solutions), Cenetron (Versiti Clinical Trials), Vigilant Bioservices, Hong Kong Science & Technology Parks, BioArkive, Precision Stability Storage, Goodwill E-health Info Co, Tescor, Birka BioStorag, Shanghai Biochip Co, Albetra

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 128 pages
Market size 2025
$689
Million USD
Forecast CAGR
12.3%
2025-2032
Forecast 2032
$1551.9
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Biostorage Service market size is predicted to grow from US$ 689 million in 2025 to US$ 1,542 million in 2032; it is expected to grow at a CAGR of 12.3% from 2026 to 2032.

Biostorage services refer to the secure and controlled storage of biological materials such as cells, tissues, blood, DNA, and other biomolecules. These services are crucial for maintaining the viability, stability, and integrity of samples, ensuring their usability for research, clinical, and diagnostic applications. Biostorage facilities utilize specialized equipment like freezers, refrigerators, and liquid nitrogen tanks, along with temperature monitoring systems, to maintain samples at specific, controlled conditions.

With the continuous advancement of precision medicine, multiple application scenarios such as clinical diagnosis and new drug development have put forward higher requirements for the scale of biological samples. Traditional sample management relies on manual work, which is not conducive to the sustainable growth and effective management of the number of biological sample storage. First, there is the possibility of information recording errors or omissions; at the same time, the sample access process needs to be completed manually, and the storage device needs to be opened for manual search. During this process, the low-temperature storage device will produce temperature fluctuations and freeze-thaw cycles, affecting the stability of all samples in the inventory, resulting in a decrease in sample quality. The rapid development of cryogenic storage technology and equipment, and the continuous optimization of intelligent biological sample processing processes have promoted the rapid development of the biological sample storage industry.

In recent years, the construction of biobanks has become a strategic action of major developed countries in Europe and the United States. In 2009, Time Magazine listed the construction of biobanks as one of the top ten plans to change the world in the future. China is a populous country with extremely rich types of diseases and genetic resources in the population. At the same time, it is a multi-ethnic country with diversity and local characteristics of major disease resources, and has inherent advantages in building biobanks.

Biological sample storage institutions have gradually opened up their applications to clinical hospitals, research institutions and technology companies, and accelerated cooperation with other institutions to provide clinical trials and medical translation research services to achieve resource value-added.

With the rapid development of life science and technology, translational medicine that accelerates basic research and clinical treatment plays a huge role in improving people's health and quality of life. Biological sample storage service providers provide large-scale sample resources and long-term storage conditions, which is conducive to promoting the development of industries such as medicine and scientific research.

This report presents a comprehensive overview of the global Biostorage Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Room Temperature Storage
  • Refrigerated Storage
  • Frozen Storage
  • Ultra Low Temperature Storage
  • Liquid Nitrogen Storage

Segment by players, this report covers

  • Azenta
  • EPL Archives (VWR)
  • Thermo Fisher Scientific
  • Precision for Medicine
  • Kryosphere
  • Cryoport Inc
  • Masy BioServices (Alcami)
  • SciSafe (BioLife Solutions)
  • Cenetron (Versiti Clinical Trials)
  • Vigilant Bioservices
  • Hong Kong Science & Technology Parks
  • BioArkive
  • Precision Stability Storage
  • Goodwill E-health Info Co
  • Tescor
  • Birka BioStorag
  • Shanghai Biochip Co
  • Albetra

Segment by Application

  • Life Sciences and Medicine
  • Hospital
  • Government and Scientific Research Institutions
  • Chemical Industry
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Biostorage Service market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Life Sciences and Medicine, Hospital, Government and Scientific Research Institutions evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Biostorage Service Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 12.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$689
2025
Forecast
$1551.9
2032
CAGR
12.3%
2025–2032
リージョン
5
global
Key companies
AzentaEPL Archives (VWR)Thermo Fisher ScientificPrecision for MedicineKryosphereCryoport IncMasy BioServices (Alcami)SciSafe (BioLife Solutions)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Room Temperature StorageRefrigerated StorageFrozen StorageUltra Low Temperature StorageLiquid Nitrogen Storage
By Application
Life Sciences and MedicineHospitalGovernment and Scientific Research InstitutionsChemical IndustryOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Room Temperature Storage
  • 3.1.3 Refrigerated Storage
  • 3.1.4 Frozen Storage
  • 3.1.5 Ultra Low Temperature Storage
  • 3.1.6 Liquid Nitrogen Storage
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Life Sciences and Medicine
  • 4.1.3 Hospital
  • 4.1.4 Government and Scientific Research Institutions
  • 4.1.5 Chemical Industry
  • 4.1.6 Other
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Azenta
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 EPL Archives (VWR)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Thermo Fisher Scientific
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Precision for Medicine
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Kryosphere
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Cryoport Inc
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Masy BioServices (Alcami)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 SciSafe (BioLife Solutions)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Cenetron (Versiti Clinical Trials)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Vigilant Bioservices
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Hong Kong Science & Technology Parks
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 BioArkive
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Precision Stability Storage
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Goodwill E-health Info Co
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Tescor
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Birka BioStorag
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Shanghai Biochip Co
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Albetra
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Biostorage Service market size?
The global Biostorage Service market is estimated at US$ 689 million in 2025 (base year) and is projected to reach US$ 1.54 billion by 2032.
What growth rate is expected for the Biostorage Service market through 2032?
The market is expected to grow at a CAGR of 12.3% from 2026 to 2032, expanding from US$ 689 million in 2025 to US$ 1.54 billion in 2032, roughly 2.2 times its base-year value.
How is Biostorage Service defined?
Biostorage services refer to the secure and controlled storage of biological materials such as cells, tissues, blood, DNA, and other biomolecules. These services are crucial for maintaining the viability, stability, and integrity of samples, ensuring their usability for research, clinical, and diagnostic applications. Biostorage facilities utilize specialized equipment like freezers, refrigerators, and liquid nitrogen tanks, along with temperature monitoring systems, to maintain samples at specific, controlled conditions.
What are the main segments of the Biostorage Service market by type?
By type, the market is segmented into Room Temperature Storage, Refrigerated Storage, Frozen Storage, Ultra Low Temperature Storage and Liquid Nitrogen Storage.
Which applications drive demand in the Biostorage Service market?
Key applications covered include Life Sciences and Medicine, Hospital, Government and Scientific Research Institutions, Chemical Industry and Other.
Who are the key players in the Biostorage Service market?
Key players profiled include Azenta, EPL Archives (VWR), Thermo Fisher Scientific, Precision for Medicine, Kryosphere, Cryoport Inc, Masy BioServices (Alcami) and SciSafe (BioLife Solutions), among 18 companies covered in total.
Which regions and countries are covered for Biostorage Service?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Biostorage Service market report?
The report is intended for manufacturers and solution providers, distributors and end users in Life Sciences and Medicine, Hospital and Government and Scientific Research Institutions, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Biostorage Service market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.